DC661
CAS: 1872387-43-3
Ref. 3D-XZC38743
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
DC-661 is a new compound that is being developed for the treatment of cancer. DC-661 is a stable complex of an amp-activated protein with rapamycin and has shown to have anti-cancer effects in cell culture. The mechanism of action of DC-661 against cancer cells may be due to its ability to induce autophagy, a process that eliminates dysfunctional or unnecessary cellular components. This compound also inhibits the expression of death proteins, which leads to apoptosis (cell death). Pentobarbital sodium, an anaesthetic agent, has been shown to inhibit autophagy in mice and this may be one possible mechanism for its use as an anticancer agent.
Chemical properties
Technical inquiry about: 3D-XZC38743 DC661
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
